Suppr超能文献

眼睑默克尔细胞癌:组织学和免疫组化特征,特别关注鉴别诊断

Merkel cell carcinoma of the eyelid: histological and immunohistochemical features with special respect to differential diagnosis.

作者信息

Metz K A, Jacob M, Schmidt U, Steuhl K P, Leder L D

机构信息

Institut für Pathologie, Universitätsklinik Essen, Germany.

出版信息

Graefes Arch Clin Exp Ophthalmol. 1998 Aug;236(8):561-6. doi: 10.1007/s004170050121.

Abstract

BACKGROUND

Merkel cell carcinomas (MCC) not infrequently involve the periorbital region and the eyelids. Clinically, they are relatively characteristic but often unsuspected. Histologically, MCC are often misdiagnosed as lymphoma, melanoma, or metastatic small cell carcinoma of the lung (SCCL).

METHODS

We present clinical, histological, and immunohistochemical data on six eyelid cases (all females; age 63-102 years; one with concomitant CLL) from our files of 77 MCC with special respect to differential diagnosis. For comparison, 22 SCCL were analyzed. Immunohistochemistry was done with antibodies against pan-cytokeratin (pan-CK), cytokeratin-20 (CK-20), neurofilament protein (NF), neuron-specific enolase (NSE), chromogranin (CHR), and S100 protein (S100).

RESULTS

Morphologically, five of six MCC were prototypic, one was of the small cell variant. Immunohistochemically, dot-like positivities for pan-CK and CK-20 were seen in all six MCC, and for NF in five tumors. None of the 22 SCCL stained positively for CK-20 or NF but 21/22 cases were positive for pan-CK. Only 1/21 SCCL showed dot-like patterns for pan-CK; 20/21 reacted diffusely. All MCC and 13/22 SCCL displayed CHR-positive cells. All MCC and all SCCL were positive for NSE and negative for S100.

CONCLUSIONS

Dot-like positivities for CK-20 or NF are important to prove MCC and to exclude SCCL in clinically and morphologically doubtful cases. Dot-like positivities for pan-CK favor MCC, but do not always exclude SCCL. NSE and CHR are of no value for the differential diagnosis of MCC and SCCL. Melanoma and lymphoma are ruled out by negativity for S100 and pan-CK, respectively.

摘要

背景

默克尔细胞癌(MCC)常累及眶周区域和眼睑。临床上,它们相对具有特征性,但常被漏诊。组织学上,MCC常被误诊为淋巴瘤、黑色素瘤或肺转移性小细胞癌(SCCL)。

方法

我们提供了来自我们77例MCC病例档案中的6例眼睑病例(均为女性;年龄63 - 102岁;1例合并慢性淋巴细胞白血病)的临床、组织学和免疫组化数据,特别关注鉴别诊断。作为对照,分析了22例SCCL。免疫组化使用抗泛细胞角蛋白(pan - CK)、细胞角蛋白 - 20(CK - 20)、神经丝蛋白(NF)、神经元特异性烯醇化酶(NSE)、嗜铬粒蛋白(CHR)和S100蛋白(S100)的抗体进行。

结果

形态学上,6例MCC中有5例为典型型,1例为小细胞变异型。免疫组化方面,所有6例MCC中均可见pan - CK和CK - 20的点状阳性,5例肿瘤中可见NF阳性。22例SCCL中无一例CK - 20或NF染色阳性,但21/22例pan - CK阳性。22例SCCL中仅1/21表现为pan - CK的点状模式;20/21呈弥漫性反应。所有MCC和13/22例SCCL显示CHR阳性细胞。所有MCC和所有SCCL的NSE均为阳性,S100均为阴性。

结论

CK - 20或NF的点状阳性对于在临床和形态学上可疑的病例中确诊MCC和排除SCCL很重要。pan - CK的点状阳性支持MCC的诊断,但并不总是排除SCCL。NSE和CHR对MCC和SCCL的鉴别诊断无价值。黑色素瘤和淋巴瘤分别通过S100和pan - CK阴性排除。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验